Fresenius Medical Care Responds To Hurricane Sandy In The Mid-Atlantic Region

Although more than 100 Fresenius Medical Care North America (FMCNA) clinics in the mid-Atlantic region were affected by Hurricane Sandy last week, all but one have now resumed operations.

FMCNA, the nation’s leading network of dialysis facilities, is pleased to report that all of its patients and employees are now accounted for and safe, even though many were personally affected by the storm, which caused power outages, widespread flooding and significant property damage.

Patients needing emergency help or information about specific dialysis clinics should call FMCNA’s toll-free Patient Emergency Hotline: 1-800-626-1297.

The Fresenius Medical Care Disaster Response Team – assisted by divisional, technical and regional employees, local governments and community organizations such as the Kidney Community Emergency Response (KCER) Coalition – worked overtime to prepare for and respond to the storm. FMCNA and its partners continue to meet daily to coordinate a variety of critical activities, such as:
  • Providing extra treatments to patients at clinics affected by the storm;
  • Arranging treatments for patients served by closed clinics, including patients from other dialysis companies;
  • Delivering generators, bottled water and warm meals to facilities and employees in need;
  • Providing gasoline for employees’ cars and personal generators across New Jersey and New York;
  • Supplying motor homes equipped with personal supplies and generators to employees who lost homes or whose homes are not safe to occupy.

“We have taken extraordinary steps to ensure uninterrupted dialysis treatments for patients,” said Bill Numbers, FMCNA Vice President of Operations Support and Incident Commander for Disaster Response and Planning. “Fortunately, our advance preparation for situations like this gave us a head start in planning how to respond quickly and effectively.”

If you liked this article you might like

Mining and Resources Lead Europe's Benchmarks Lower

European Stocks Diverge as Investors Weigh Economic Optimism With Mixed Earnings

Wednesday's Earnings Push Stocks Lower as Mood Sours in Europe

Here's What's Boosting European Benchmarks

Drug Price Inflation and a Patent Cliff Could Trigger a Wave of Deals in Generic Drugs Space